Clinical Trials Browser

Phase 3 × onartuzumab × Gastrointestinal × Clear all

NCT01662869 2016-11-02

A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer

Phase 3 Completed

Gastrointestinal

Stomach Neoplasms